Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field.
- What are the major unmet needs in the use of inhaled therapies for the control of asthma? (0:15)
- How can we help patients optimise their inhaler technique? (0:55)
- How can we maximise the benefits of inhaler therapy over 24 hours? (1:46)
- Which asthma patients are most likely to benefit from once daily single inhaler triple therapy? (2:39)
- What have been the most exciting recent developments in inhaler therapy? (3:49)
Speaker disclosure: Richard van Zyl-Smith has conducted clinical research trials for Novartis, AstraZeneca, Takeda, Merck, Almirall, Boehringer Ingelheim, Sanofi, Teva, Perl, Pfizer, Roche, GSK and Genetech. He has also received honoraria for academic talks from, Aspen, Pfizer, AstraZeneca, Novartis, Cipla, MSD, Roche, Jannsen, Boehringer Ingelheim and participated in advisory boards for GSK, Pfizer, AstraZeneca, Novartis, MSD and Roche.
Support: Interview and filming supported by Touch Medical Media.
Filmed in coverage of the ERS International Congress 2020
Share this Video
Related Videos In Asthma
Michael Wechsler, ERS 2020 – Dupilumab in the LIBERTY ASTHMA TRAVERSE Trial
We discuss with Prof. Michael Wechsler (National Jewish Health, Denver, CO, USA) the clinical evidence supporting the use of dupilumab in patients with asthma and specifically the major findings from the long-term safety evaluation of dupilumab in the LIBERTY ASTHMA TRAVERSE trial (NCT02134028). Questions 1. What are the major unmet needs in the biologic treatment […]
Richard van Zyl-Smit, ERS 2020 – Optimising Inhaled Therapies for Asthma
Richard van Zyl-Smit (University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa) kindly took the time to speak with us about maximising the benefit of inhaler therapy and recent development being made in this field. Questions What are the major unmet needs in the use of inhaled therapies for the control of […]
Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!